Published in J Physiol on October 01, 1997
Adenosine-induced presynaptic inhibition of IPSCs and EPSCs in rat hypothalamic supraoptic nucleus neurones. J Physiol (1999) 1.16
GABA B receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons. J Physiol (2003) 1.14
Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol (1999) 1.09
Inhibitory-excitatory synaptic balance is shifted toward increased excitation in magnocellular neurosecretory cells of heart failure rats. J Neurophysiol (2011) 1.08
Synchronized bursts of miniature inhibitory postsynaptic currents. J Physiol (2010) 0.98
Differences in spike train variability in rat vasopressin and oxytocin neurons and their relationship to synaptic activity. J Physiol (2007) 0.94
Inhibition of N- and P/Q-type calcium channels by postsynaptic GABAB receptor activation in rat supraoptic neurones. J Physiol (1998) 0.90
Baclofen inhibits guinea pig magnocellular neurones via activation of an inwardly rectifying K+ conductance. J Physiol (2003) 0.89
Enhanced neurotransmitter release at glutamatergic synapses on oxytocin neurones during lactation in the rat. J Physiol (2000) 0.88
Oxytocin retrogradely inhibits evoked, but not miniature, EPSCs in the rat supraoptic nucleus: role of N- and P/Q-type calcium channels. J Physiol (2001) 0.86
Modulation of neurotransmission by GPCRs is dependent upon the microarchitecture of the primed vesicle complex. J Neurosci (2014) 0.85
Acid-sensing ion channels in rat hypothalamic vasopressin neurons of the supraoptic nucleus. J Physiol (2010) 0.85
Long-lasting hyperpolarization underlies seizure reduction by low frequency deep brain electrical stimulation. J Physiol (2013) 0.83
Plasticity of pre- and postsynaptic GABAB receptor function in the paraventricular nucleus in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2008) 0.83
Tonic regulation of GABAergic synaptic activity on vasopressin neurones by cannabinoids. J Neuroendocrinol (2012) 0.81
Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus. J Neurosci (2010) 0.81
Role of GABA receptors in nitric oxide inhibition of dorsolateral periaqueductal gray neurons. Neuropharmacology (2008) 0.80
Short-term potentiation of mEPSCs requires N-, P/Q- and L-type Ca2+ channels and mitochondria in the supraoptic nucleus. J Physiol (2008) 0.78
Multivesicular release underlies short term synaptic potentiation independent of release probability change in the supraoptic nucleus. PLoS One (2013) 0.77
Effects of nitric oxide on magnocellular neurons of the supraoptic nucleus involve multiple mechanisms. Braz J Med Biol Res (2014) 0.75
GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature (1986) 3.01
Functional domains of GABAA receptors. Trends Pharmacol Sci (1995) 2.10
GABA: a dominant neurotransmitter in the hypothalamus. J Comp Neurol (1990) 2.08
Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron (1992) 2.06
Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells. Nature (1984) 1.98
GABAC receptors. Trends Neurosci (1995) 1.76
Mechanosensitive channels transduce osmosensitivity in supraoptic neurons. Nature (1993) 1.66
Contributions of calcium-dependent and calcium-independent mechanisms to presynaptic inhibition at a cerebellar synapse. J Neurosci (1996) 1.60
Perpetual inhibitory activity in mammalian brain slices generated by spontaneous GABA release. Brain Res (1991) 1.52
GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci (1992) 1.51
Comparison of the actions of baclofen at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol (1992) 1.48
Kinetics of GABAB receptor-mediated inhibition of calcium currents and excitatory synaptic transmission in hippocampal neurons in vitro. Neuron (1994) 1.29
GABAB receptor-mediated inhibition of Ca2+ currents and synaptic transmission in cultured rat hippocampal neurones. J Physiol (1991) 1.27
Calcium channel involvement in GABAB receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus. J Neurophysiol (1995) 1.26
Multiple GABAB receptors. Trends Pharmacol Sci (1993) 1.21
On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol (1990) 1.11
Actions of gamma-aminobutyric acid on rat supraoptic nucleus neurosecretory neurones in vitro. J Physiol (1987) 1.08
Patch-clamp analysis of spontaneous synaptic currents in supraoptic neuroendocrine cells of the rat hypothalamus. J Neurosci (1993) 1.07
gamma-Aminobutyric acid (GABA) causes consistent depolarization of neurons in the guinea pig supraoptic nucleus due to an absence of GABAB recognition sites. Brain Res (1987) 1.06
Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J Neurophysiol (1996) 1.04
Immunocytochemical analysis of the GABAergic innervation of oxytocin- and vasopressin-secreting neurons in the rat supraoptic nucleus. Neuroscience (1986) 1.02
Glutamate and aspartate immunoreactivity in hypothalamic presynaptic axons. J Neurosci (1991) 1.02
GABAB receptors presynaptically modulate excitatory synaptic transmission in the rat supraoptic nucleus in vitro. J Neurophysiol (1996) 0.98
Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther (1992) 0.96
Light and electron microscopic localization of glutamate immunoreactivity in the supraoptic nucleus of the rat hypothalamus. Neuroscience (1989) 0.91
Properties of the GABAA receptor of rat posterior pituitary nerve terminals. J Neurophysiol (1995) 0.91
Quantitative mapping of glutamate presynaptic terminals in the supraoptic nucleus and surrounding hypothalamus. Brain Res (1993) 0.90
On the inhibitory actions of baclofen and gamma-aminobutyric acid in rat ventral midbrain culture. J Physiol (1992) 0.90
Presynaptic inhibition by baclofen of retinohypothalamic excitatory synaptic transmission in rat suprachiasmatic nucleus. Neuroscience (1995) 0.90
Ionotropic glutamate-receptor gene expression in hypothalamus: localization of AMPA, kainate, and NMDA receptor RNA with in situ hybridization. J Comp Neurol (1994) 0.90
Effects of the putative antagonists phaclofen and delta-aminovaleric acid on GABAB receptor biochemistry. Br J Pharmacol (1989) 0.88
Fast presynaptic GABAA receptor-mediated Cl- conductance in cultured rat hippocampal neurones. J Physiol (1994) 0.86
gamma-Aminobutyric acid as an inhibitory neurotransmitter in the rat supraoptic nucleus: intracellular recordings in the hypothalamic slice. Neurosci Lett (1987) 0.85
Transient outward current in adult rat supraoptic neurones with slice patch-clamp technique: inhibition by angiotensin II. J Physiol (1995) 0.85
Osmotic modulation in glutamatergic excitatory synaptic inputs to neurons in the supraoptic nucleus of rat hypothalamus in vitro. J Neuroendocrinol (1997) 0.81
Influence of atrial stretch receptors on hypothalamic neurosecretory neurones. J Physiol (1978) 0.80
Effects of central GABAB receptor modulation upon the milk ejection reflex in the rat. Neuroendocrinology (1996) 0.80
gamma-Aminobutyric acid antagonist blocks baroreceptor-activated inhibition of neurosecretory cells in the hypothalamic paraventricular nucleus of rats. Neurosci Lett (1987) 0.80
Bicuculline blocks an inhibitory baroreflex input to supraoptic vasopressin neurons. Am J Physiol (1987) 0.79
Neuronal activity of the cat supraoptic nucleus is influenced by muscle small-diameter afferent (groups III and IV) receptors. Proc Natl Acad Sci U S A (1988) 0.78
GABAergic inputs modulate effects of interleukin-1 beta on supraoptic neurones in vitro. Neuroreport (1993) 0.77
Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature (1997) 6.73
Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest (1998) 4.94
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell (1993) 3.57
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem (1994) 3.49
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol (2004) 2.95
Characterization of type I receptors for transforming growth factor-beta and activin. Science (1994) 2.94
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis (1998) 2.40
Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A (1999) 2.39
Cerebral arteriovenous malformations: factors influencing the surgical difficulty and outcome. Neurosurgery (1991) 2.36
Amnestic people with Alzheimer's disease who remembered the Kobe earthquake. Br J Psychiatry (1998) 2.26
Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature (1995) 2.20
Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A (1995) 2.19
Subcutaneous release of trigger thumb and fingers in 210 fingers. J Hand Surg Br (1990) 2.05
Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut (2005) 2.02
Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ Res (1998) 1.94
Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain (2009) 1.82
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol (2009) 1.73
Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) (2006) 1.73
Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem (1996) 1.72
UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell (2005) 1.68
Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke (1982) 1.67
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene (2009) 1.66
Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg (2001) 1.65
Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem (2000) 1.61
Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer (1998) 1.57
Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia (1989) 1.55
High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J (2001) 1.53
Phosphorylation-dependent power output of transgenic flies: an integrated study. Biophys J (1997) 1.50
Viability of an Escherichia coli pgsA null mutant lacking detectable phosphatidylglycerol and cardiolipin. J Bacteriol (2000) 1.50
Supernumerary head of biceps brachii and branching pattern of the musculocutaneus nerve in Japanese. Surg Radiol Anat (1992) 1.50
Neuroprotective mechanism of bromocriptine. Lancet (1995) 1.48
Disruption of the Escherichia coli cls gene responsible for cardiolipin synthesis. J Bacteriol (1988) 1.43
Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry (2002) 1.43
Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J Hepatol (2001) 1.41
Alteration of phospholipid composition by combined defects in phosphatidylserine and cardiolipin synthases and physiological consequences in Escherichia coli. J Bacteriol (1985) 1.41
Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol (1989) 1.39
Isolated prolonged retrograde amnesia. Eur Neurol (1992) 1.39
Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg (1998) 1.35
Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia (2010) 1.33
Studies of antidromically identified neurosecretory cells of the hypothalamus by intracellular and extracellular recordings. J Physiol (1972) 1.33
Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol (2000) 1.31
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem (1999) 1.28
A new potent excitant, quisqualic acid: effects on crayfish neuromuscular junction. Neuropharmacology (1974) 1.27
Active increase in cardiolipin synthesis in the stationary growth phase and its physiological significance in Escherichia coli. FEBS Lett (1993) 1.26
Phasically firing neurons in the supraoptic nucleus of the rat hypothalamus: immunocytochemical and electrophysiological studies. Neurosci Lett (1983) 1.25
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol (1999) 1.25
Incidence of stroke in Shibata, Japan: 1976-1978. Stroke (1982) 1.24
Angiographic classification of aneurysms of the horizontal segment of the anterior cerebral artery. Surg Neurol (1985) 1.22
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol (2002) 1.21
Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma). Cancer (1985) 1.21
Scar remodeling and transmural deformation after infarction in the pig. Circulation (1994) 1.21
Membrane phospholipid synthesis and phenotypic correlation of an Escherichia coli pss mutant. J Bacteriol (1977) 1.21
Drastic alteration of cycloheximide sensitivity by substitution of one amino acid in the L41 ribosomal protein of yeasts. J Bacteriol (1992) 1.21
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol (1992) 1.19
Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett (2001) 1.19
Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res (2002) 1.19
Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport (2000) 1.18
Current management and long-term prognosis of hepatolithiasis. Arch Surg (1995) 1.18
Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry (1997) 1.17
Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci (2000) 1.14
Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry (1997) 1.14
Choroidal circulation in diabetic patients. Eye (Lond) (2001) 1.14
Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg (1996) 1.13
Effects of kainic acid analogues on crayfish opener muscle. Neuropharmacology (1976) 1.13
The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol (2007) 1.13
Autolytic formation of spheroplasts and autolysis of cell walls in Clostridium botulinum type A. Jpn J Microbiol (1968) 1.13
Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina (2001) 1.12
Genetic manipulation of membrane phospholipid composition in Escherichia coli: pgsA mutants defective in phosphatidylglycerol synthesis. Proc Natl Acad Sci U S A (1985) 1.12
An extremely labile phosphatidylserine synthetase of an Escherichia coli mutant with the temperature-sensitive formation of phosphatidylethanolamine. Biochim Biophys Acta (1974) 1.12
Domain structures and immunogenic regions of the 90-kDa heat-shock protein (HSP90). Probing with a library of anti-HSP90 monoclonal antibodies and limited proteolysis. J Biol Chem (1997) 1.11
Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid (1998) 1.11
Preparation and properties of an active membrane system from Escherichia coli. J Biochem (1967) 1.10
Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology (1998) 1.10
Primary structure and product characterization of the Saccharomyces cerevisiae CHO1 gene that encodes phosphatidylserine synthase. J Biochem (1987) 1.10
Biosynthesis of novel acidic phospholipid analogs in Escherichia coli. J Bacteriol (1985) 1.10
Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype. Neurology (2003) 1.10
Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia (2011) 1.10
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J (1995) 1.09
Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol (1999) 1.09
Effects of hypobaric hypoxia on antioxidant enzymes in rats. J Physiol (1995) 1.09
Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer (2002) 1.08
Cloning, sequencing, and expression in Escherichia coli of the Bacillus subtilis gene for phosphatidylserine synthase. J Bacteriol (1994) 1.08
Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol (1998) 1.08
Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. Int J Cancer (2001) 1.08
Multiple arteriovenous malformations involving the scalp, dura, retina, cerebrum, and posterior fossa. Case report. J Neurosurg (1971) 1.08
Disruption of the CHO1 gene encoding phosphatidylserine synthase in Saccharomyces cerevisiae. J Biochem (1988) 1.07
Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin. J Physiol (1986) 1.06
Relationship between the pathogenicity of the pine wood nematode, Bursaphelenchus xylophilus, and phenylacetic acid production. Biosci Biotechnol Biochem (1996) 1.06
Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US. Eur J Nucl Med (2001) 1.05
A regulatory mechanism for the balanced synthesis of membrane phospholipid species in Escherichia coli. Biosci Biotechnol Biochem (1996) 1.05
Progenitor cell cycling during hair cell regeneration in the vestibular and auditory epithelia of the chick. J Neurocytol (2000) 1.05
Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplant (2008) 1.05